Urinary Tract Pathogen Test

The UTI PCR panel offered by Genuvi provides rapid, comprehensive, and clinically relevant results for the effective management of urinary tract infections. With its broad pathogen coverage, antibiotic resistance profiling, and fast turnaround time, it is an essential tool in modern urological and infectious disease care. This panel enhances diagnostic accuracy, enables timely treatment, and promotes the responsible use of antibiotics.

Price

$85.00

USD

Would you like us to call you?

One of our agents will contact you

Introduction

Urinary tract infections (UTIs) are among the most common bacterial infections, with significant implications for morbidity, antibiotic resistance, and healthcare costs.

Overview

The PCR panel for UTIs, developed by Genuvi, uses high-performance molecular diagnostics to detect pathogens and resistance genes with high sensitivity and rapid turnaround. This test offers greater accuracy than traditional culture methods, enabling earlier diagnosis, better antibiotic management, and personalized patient care.

Who benefits from the PCR test for urinary tract infections?

This test is ideal for:

- Patients with symptoms suggestive of a UTI: dysuria, urgency, hematuria
- Individuals with recurrent or chronic UTIs
- Immunocompromised or elderly patients
- Patients with catheter-associated UTIs
- Individuals who have failed empirical antibiotic therapy
- Pediatric or geriatric populations where rapid diagnosis is essential

Panel Content and Functional Coverage

The UTI PCR panel includes:

Fungal pathogens:

- Candida krusei
- Candida species (albicans, glabrata, parapsilosis, tropicalis)
- Bacterial pathogens:
- Acinetobacter baumannii
- Citrobacter freundii
- Enterobacter cloacae complex
- Enterococcus faecalis
- Enterococcus faecium
- Klebsiella (Enterobacter) aerogenes
- Klebsiella oxytoca
- Klebsiella pneumoniae
- Morganella morganii
- Proteus species (mirabilis, vulgaris)
- Pseudomonas aeruginosa
- Staphylococcus aureus
- Staphylococcus epidermidis
- Staphylococcus saprophyticus
- Streptococcus agalactiae
- Ureaplasma urealyticum

Antibiotic resistance genes:

- ampC (beta-lactamase gene)
- erm(A) (erythromycin resistance methylase)
- mecA (methicillin resistance)
- qnrB (quinolone resistance)
- vanA, vanB, vanC (vancomycin resistance genes)

Technical Specifications

Panel type: Real-time multiplex PCR
Sample type: Urine
Detected pathogens: Bacteria, fungi, and resistance genes (49 total targets)
Turnaround time: 24 hours from sample receipt
Technology platform: High-sensitivity PCR with validated primer sets
Reporting standards: Clinically actionable interpretation; includes detection of resistance genes

Test Methodology

ChatGPT dijo:

The PCR panel for urinary tract infections (UTIs) uses real-time multiplex polymerase chain reaction (RT-PCR) technology to detect microbial DNA with high specificity and sensitivity. Specific primers and probes for pathogens amplify targeted regions of bacterial and fungal genomes. Detection of resistance genes is included to help guide antibiotic selection.

All PCR reactions are performed according to validated laboratory protocols. Quality control includes both internal and external controls, and reports are generated with interpretations relevant to the patient’s clinical condition.

This panel is particularly useful for patients who require rapid identification of urinary tract infection pathogens and determination of antimicrobial resistance.

Conclusion

The UTI PCR panel offered by Genuvi provides rapid, comprehensive, and clinically relevant results for the effective management of UTIs. With its broad pathogen coverage, antibiotic resistance profiling, and fast turnaround time, it serves as an essential tool in modern urological and infectious disease care. This panel enhances diagnostic accuracy, enables timely treatment, and promotes the responsible use of antibiotics.